EMA recommends marketing authorisation for Ulipristal Acetate Gedeon Richter

…original products. The announcement is not associated with the ongoing investigation of Esmya. Gedeon Richter is, at present, awaiting a European Commission decision before it restarts the distribution of the product. The Esmya patent will expire in 2020 in the EU and in 2029 in the US.

Sign up now to open the entire news item.

You are allowed to open only one news item from PMR websites.
  • 1E-mail
    (to send requested information)
  • 2Brief profile
    (required for new e-mails only)

 required fields

You must accept PMR’s Privacy Policy.